Gevokizumab Completed Phase 2 Trials for Acne Vulgaris Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01498874Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris